Loading company…
Develops lipid nanoparticle technologies for delivering nucleic acids, including mRNA therapies.
NanoVation Therapeutics develops lipid nanoparticle formulations for delivering nucleic acids, with a focus on mRNA therapies and delivery to tissues outside the liver. Its systems are designed for pharmaceutical companies and research institutions. Founded in 2020, the company is based in Vancouver, Canada. It raised venture funding led by Convergent Ventures in November 2024.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in